Biohaven
BHVN
256 hedge funds and large institutions have $3.48B invested in Biohaven in 2024 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 103 increasing their positions, 64 reducing their positions, and 41 closing their positions.
98% more call options, than puts
Call options by funds: $34.9M | Put options by funds: $17.6M
61% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 64
15% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 41
1% more funds holding
Funds holding: 254 → 256 (+2)
0.11% more ownership
Funds ownership: 91.15% → 91.26% (+0.11%)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
19% less capital invested
Capital invested by funds: $4.31B → $3.48B (-$823M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$54.6M |
| 2 |
BlackRock
New York
|
+$36.9M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$36.7M |
| 4 |
Janus Henderson Group
London,
|
+$35.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$74.2M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$42.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$26.9M |
| 4 |
D.E. Shaw & Co
New York
|
-$19M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$16.2M |
BHVN Hedge Fund Activity: Q4 2024 in Review
256 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q4 2024, worth a combined $3.48B — down 19% from $4.31B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new BHVN positions and 41 closed out — a net gain of 6 holders — while 103 added to existing stakes and 64 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $54.6M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $74.2M sold.
- 256 institutional investors held Biohaven (BHVN) as of Q4 2024, up from 254 in Q3 2024.
- Funds reported $3.48B of Biohaven stock for Q4 2024, down 19% quarter-over-quarter.
- 47 funds opened new Biohaven positions in Q4 2024 and 41 closed out, a net change of +6 holders.
- The largest Biohaven buyer in Q4 2024 was JP Morgan Chase, an estimated $54.6M added.
- The largest Biohaven seller in Q4 2024 was Perceptive Advisors, an estimated $74.2M sold.
Based on aggregated 13F filings for Q4 2024.